Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCitius Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Citius Pharmaceuticals, Inc.

$0.60Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $1.49M. Net result −$11.92M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $1.49M. Running result $1.49M. Revenue: $1.49M.
  • Cost of revenue: −$491.84K. Running result $1M.
  • Gross profit: $1M. Running result $1M.
  • Research and development: −$1.05M. Running result −$51.92K.
  • Amortization of in-process research and development: −$1.72M. Running result −$1.77M.
  • General and administrative: −$6.15M. Running result −$7.92M.
  • Stock-based compensation – general and administrative: −$3.81M. Running result −$11.73M.
  • Operating income: −$11.73M. Running result −$11.73M.
  • Other expense: −$294.53K. Running result −$12.03M.
  • Pre-tax loss: −$12.03M. Running result −$12.03M.
  • Income tax benefit: $107.35K. Running result −$11.92M.
  • Net loss: −$11.92M. Running result −$11.92M.